Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing adoption of advanced skin care procedures
3.2.1.2 Increasing prevalence of hypopigmentation disorders
3.2.1.3 Growing expenditure on dermatological treatments
3.2.1.4 Rising awareness regarding skin health among younger population
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of cosmetic procedures
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter’s analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Drugs
5.2.1 By type
5.2.1.1 Corticosteroids
5.2.1.2 Melanocyte-stimulating hormone
5.2.1.3 Other drugs
5.2.2 By route of administration
5.2.2.1 Oral
5.2.2.2 Topical
5.2.2.3 Other routes of administrations
5.2.3 By distribution channel
5.2.3.1 Hospital pharmacies
5.2.3.2 Retail pharmacies
5.2.3.3 Online pharmacies
5.3 Procedures
5.3.1 By type
5.3.1.1 Laser treatment
5.3.1.2 Phototherapy
5.3.1.3 Microdermabrasion
5.3.1.4 Other procedures
5.3.2 By end-user
5.3.2.1 Hospitals
5.3.2.2 Dermatology clinics
5.3.2.3 Aesthetic centers
5.3.2.4 Other end-users
Chapter 6 Market Estimates and Forecast, By Disease Indication, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Vitiligo
6.3 Albinism
6.4 Other disease indications
Chapter 7 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 AbbVie Inc.
8.2 Aclaris Therapeutics, Inc.
8.3 Bayer AG
8.4 Candela Corporation
8.5 Galderma
8.6 Incyte
8.7 Novartis AG
8.8 Pfizer Inc.
8.9 Pierre Fabre group
8.10 Shiseido Company Limited
8.11 UNIZA Group
